Warning Signs Y es No Unk Persistent Vomiting…………..... Abdominal pain/Tenderness.. Mucosal Bleeding …………….. Lethargy, restlessness……….… Liver Enlargement.

Slides:



Advertisements
Similar presentations
DENGUE HEMORRHAGIC FEVER
Advertisements

HISTORY TAKING OF FEVER
Hepatitis A to E: An Overview
Flight Surgeon RSV Day I n t e g r i t y - S e r v i c e - E x c e l l e n c e ANGRC Joint Base Andrews UNCLASSIFIED.
Development Committee
Acute Retroviral Syndrome
EVD is a preventable but often fatal viral infection An EVD outbreak is affecting countries in West Africa where disease control resources are very limited.
Ebola Virus Disease. EVD Description Hemorrhagic fever with case fatality rate up to 90% Endemic areas: Central and West Africa Wildlife reservoir: bats.
III. Clinical Manifestations of Dengue and Dengue Hemorrhagic Fever CENTERS FOR DISEASE CONTROL AND PREVENTION.
Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Part 1 DESCRIPTIVE EPIDEMIOLOGY 1. Objectives Describe the components of descriptive epidemiology Describe the uses and importance of descriptive epidemiology.
Management of Dengue Fever Dr David Tran 16/09/09.
Re-emergence of locally acquired Dengue Fever in Palm Beach County, Florida Robert Parkes, MD; Sandra Warren, MPH, JoEllen Alvarez, RN, MPH, Barbara.
By Abhinay Sharma Bhugoo.  1648: First recognized outbreak of YF occurring in the New World. YF virus most likely introduced by slave- trading vessels.
Dengue fever in Singapore & Pakistan. Introduction The most common mosquito-borne viral disease in the world Caused by a virus transmitted by the Aedes.
Testing algorithms used at Bureau of Labs Michigan Department of Community Health Information on testing algorithms for processing and reporting serological.
TM Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention.
Dengue Virus Causes dengue and dengue hemorrhagic fever
OnSite Rubella IgG/IgM Rapid Test Novel Unique & Only Semi-Quantitative 4-Line Rapid Test.
Laboratory Investigation
Hepatitis By: Mst Tabassum. History Early case in the 18 th century By 1885, it was showed to be transmittable through blood transfusion and syringes.
DENGUE & DENGUE HEMORRHAGIC FEVER Rab Chaudhry + Arzaan Shaikh.
DR. M MOHAMMED ARIF. ASSOCIATE PROFESSOR. CONSULTANT VIROLOGIST. HEAD OF THE VIROLOGY UNIT. Arboviruses.
AN ELDERLY WOMAN WITH A FEVER Case Presentatoin Dr M Haghighi.
Medieval Diseases By: Darius Cal Warning: some of this material may be to graphic for young viewers. Read at your own risk.
Andrea Montelibano Isabelle Escobillo. The Virus Flavivirus Single strand RNA 4 serotypes – DENV-1 – DENV-2 – DENV-3 – DENV-4 Infection with one serotype.
OCCUPATIONAL SAFETY AND HEALTH ADMINSTRATION This is a branch of the US Department of Labor, responsible for protecting the health and safety of workers.
 An acute, severe viral infection  First appeared in 1976 in two simultaneous outbreaks  in a village near the Ebola River in the Democratic Republic.
agents that invade the body and cause diseases. List and describe the 5 main pathogens and how they are treated..
Facility ID: Vaccination #: Healthcare Worker Demographics *HCW ID#: HCW Name, Last:First:Middle: *Gender:  F  M *Date of Birth: *Work Location: *Occupation:
Rash Decisions: The Colorado Experience with “Maybe Measles” Emily Spence Davizon, Colorado Department of Public Health and Environment.
Dengue ..
Examples of Viruses. Influenza Seasonal Influenza: Flu Basics Influenza (the flu) is contagious respiratory disorder. It can cause mild to severe illness,
DR. MOHAMMED ARIF. ASSOCIATE PROFESSOR AND CONSULTANT VIROLOGIST. Non-arboviruses associated with zoonotic diseases.
Tropical Fevers Case 1: 27 year old woman comes to a local health unit with history of a gradual onset of fever and headache and loss of appetite over.
PHILHEALTH CLINICAL PATHWAYS CLINICAL GUIDELINES.
Submitted by: Susan Henry Keith Noble
Crimean-Congo hemorrhagic fever virus Syeda Zainab Ali Bukhari
Blood Borne Infections AIDS & HEPATITIS B Prevention for Healthcare Workers There is others out there!
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Facility ID:Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M*Date of Birth: Ethnicity (specify):Race.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
Purposes of NHSN Participation in the NHSN reflects the individual facility’s need for high quality and timely data on adverse events and adherence to.
Facility ID#: Med Admin#: Healthcare Worker Demographics *HCW ID#: *HCW Name, Last:First:Middle: *Gender:  F  M  Other *Date of Birth:// *Work Location:*Occupation:
Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the WHO Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005 R2.
The Case of the Mystery Disease.  Public Health Official  Physician  Laboratory Scientist  Field Researcher.
*Facility ID:*Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M Other *Date of Birth: Ethnicity (specify):Race.
DENGUE CASE INVESTIGATION REPORT CDC Dengue Branch and Puerto Rico Department of Health 1324 Calle Cañada, San Juan, P. R Tel. (787) ,
Facility Information: *Facility Name: __________________________________________________________________ *Main Telephone Number: ( ) ______-____________.
Diagnostic Testing for Zika Virus Frederick S. Nolte, PhD, D(ABMM), F(AAM) Professor and Vice-Chair for Laboratory Medicine Department of Pathology and.
VIRAL HAEMORRHAGIC FEVERS BY DR UCHE UNIGWE. Lassa fever Yellow fever Marburg/Ebola HF Dengue HF Crimean- Congo HF Hanta virus HF.
Internal Medicine Workshop Series Laos September /October 2009
Ebola Facts October 14, 2014.
Zika.
MALARIA By Group 8 (WHO Group)
Epidemiology Clinical features Epidemiological Investigation
Most cases occur in older children and adults
Immune System Clinical Case Problem
Dengue Fever Information for Interning
Utah Zika investigation, July 2016
Written by : Ali Mohraq Hadadi, Medical Lab Specialist
Ebola Facts October 14, 2014.
Case Definition: HEPATITIS C
Dengue Virus Infections Investigation Guideline
Dr. Keerti Singh Assistant Professor SGRRITS
Ebola Facts October 14, 2014.
Ebola Facts October 14, 2014.
Ebola Facts October 14, 2014.
Hepatitis A Infections Signs and Symptoms
Complementary algorithm for serological testing of specimens with an initial IgM-positive or indeterminate result 5 Collect an adequate serum sample within.
Presentation transcript:

Warning Signs Y es No Unk Persistent Vomiting…………..... Abdominal pain/Tenderness.. Mucosal Bleeding …………….. Lethargy, restlessness……….… Liver Enlargement >2cm……… Pleural or abdominal effusion.. Additional symptoms Diarrhea………………………….. Cough……………………………. Conjunctivitis…………………… Nasal Congestion……………... Sore throat……………………… Jaundice………………………... Convulsion or coma………….. Nausea and Vomiting……….. Arthritis (Swollen Joints)…….... YesNo _ Unk Fever Lasting 2-7 days…………….... Fever Now(>38ºC)………………..….. Platelets ≤100,000/mm 3 ………..….... Platelet count: ______________________________ Any hemorrhagic manifestation Petechiae……………………….. Purpura/Ecchymosis………….. Vomit with blood………………. Blood in stool…………………… Nasal bleeding………………… Bleeding gums…………………. Blood in urine…………………… Vaginal bleeding………………. Positive urinalysis………………. (over 5 RBC/hpf or positive for blood) Tourniquet test Not done Pos Neg DENGUE CASE INVESTIGATION REPORT CDC Dengue Branch and Puerto Rico Department of Health 1324 Calle Cañada, San Juan, P. R Tel. (787) , Fax (787) Form Approved OMB No CDC A REV. 06/2009 (Front) FOR CDC DENGUE BRANCH USE ONLY Evidence of capillary leak Lowest hematocrit (%) __________________ Highest hematocrit (%) _________________ Lowest serum albumin __________________ Lowest serum protein __________________ Lowest blood pressure (SBP/DBP) __________/_______ Lowest pulse pressure (systolic - diastolic) _________ Lowest white blood cell count (WBC) _____________ Name (complete) Relationship with patient: Tel: Fax: Who filled out this form? Physician who referred this case Name of Healthcare Provider: Tel: Fax: Send laboratory results to (mailing address) : PLEASE describe below the signs and symptoms that the patient has at the time that this form is being completed Specimen # Days post onset (DPO) Type Date Received S1 _____/_____/_____ S2 _____/_____/_____ Specimen #Days post onset (DPO)Type Date Received S3_____/_____/_____ S4_____/_____/_____ Case number GCODE SAN ID City: Zip code: __ __ __ __ __ - __ __ __ __ Tel: Other Tel: Residence is close to: Work address: Home (Physical) Address Day Month Year Date of first symptom:_______/_______/_______ Date specimen taken: Serum:First sample_______/_______/_______ (Acute = first 5 days of illness – check for virus) Second sample_______/_______/_______ (Convalescent = more than 5 days after onset – check for antibodies) Third sample_______/_______/_______ Fatal cases (tissue type):______________________________/_______/_______ Must have the following information for sample processing Please read and complete ALL sections Hospitalized due to this illness: No Yes → Hospital Name: Name of Patient: If patient is a minor, name of father or primary caregiver: Last NameFirst NameMiddle Name or Initial Fatal: YesNo Unk Mental Status Changes: Yes No Unk Date of Birth:Age:month Sex: M F _______/_______/_______ or Age: years Pregnant: Y N UNK Weeks pregnant (gestation): Patient’s Demographic Information Symptoms Yes _ No _ Unk Rapid, weak pulse……………… Pallor or cool skin………………. Chills………………………….……. Rash… Headache……………….………. Eye pain………………………….. Body (muscle/bone) pain…… Joint pain………………………… Anorexia……………………….... Additional Patient Data 1.How long have you lived in this city? 2.Country of birth 3.Have you been diagnosed with dengue before? Yes No Unk 4.When diagnosed?_______/_______ Unk Month Year 5.Got Yellow Fever Vaccine Yes No Unk Year vaccinated________________ 6.During the 14 days before onset of illness, did you TRAVEL to other cities or countries? Yes, another country Yes, another city No Unk 7.WHERE did you TRAVEL? _______________________________ Day MonthYear Home address here Patient Data Today’s date: _______/_______/_______ Day Month Year Record Number:

CDC A REV. 11/2008 (Back) DENGUE CASE INVESTIGATION REPORT FOR CDC DENGUE BRANCH USE ONLY Specimen No. S 1 _________________________________ S 2 _________________________________ S 3 _________________________________ SEROLOGY LUMINEX (MIA) S 1 S 2 S 3 Test DateAgTiterTest DateAgTiterTest DateAgTiter IgG ELISA S 1 S 2 S 3 Test DateAgScreenTiterTest DateAgScreenTiterTest DateAgScreenTiter IgM ELISA S 1 S 2 S 3 Neutralization S 1 S 2 S 3 Test DateScreenTiterTest DateScreenTiterTest DateScreenTiter DENV-1 DENV-2 DENV-3 DENV-4 WEST NILE SLE YFV Viral Isolation & PCR S 1 S 2 S 3 Test Date IDIsotechIDtech Test Date IDIsotechIDtech Test Date IDIsotechIDtech This questionnaire is authorized by law (Public Health Service Act 42 USC 241). Although response to the questions asked is voluntary, cooperation of the patient is necessary for the study and control of the disease. Public reporting burden for the collection of information is estimated to average 15 minutes per response. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing the burden to PHS Reports Clearance Officer; Rm. 721-H, Humphrey Bg; 200 Independence Ave., SW; Washington, DC 20201; ATTN: PRA, and to the Office of information and Regulatory Affaire, Office of Management and Budget, Washington, DC. CS Virology Lab Director Signature: ______________________________________ Overall dengue interpretation: _________________________________ Serology Lab Director Signature: ______________________________________ Test DateAgP/NTest DateAgP/NTest DateAgP/N